Thompson Davis & Co’s Encompass Health EHC Stock Holding History

Thompson Davis & Co’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,022	Closed	-$120K	–	1092
2016 Q1	$120K	Sell	4,022 -315	-7%	-$8.7K	0.18%	136
2015 Q4	$120K	Buy	4,337 +157	+4%	+$4.47K	0.17%	139
2015 Q3	$128K	Hold	4,180	–	–	0.18%	134
2015 Q2	$153K	Hold	4,180	–	–	0.18%	132
2015 Q1	$147K	Hold	4,180	–	–	0.18%	121
2014 Q4	$128K	Buy	4,180 +158	+4%	+$4.93K	0.15%	145
2014 Q3	$118K	Hold	4,022	–	–	0.15%	139
2014 Q2	$115K	Hold	4,022	–	–	0.17%	151
2014 Q1	$115K	Hold	4,022	–	–	0.19%	140
2013 Q4	$107K	Buy	+4,022	New	+$112K	0.16%	145

Other funds holding EHC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thompson Davis & Co's EHC Position: Q2 2016 in Review

Thompson Davis & Co sold out of Encompass Health (EHC) in Q2 2016, closing a stake of 4,022 shares — an estimated $120K sold.

Thompson Davis & Co first reported a position in EHC in Q4 2013 and held it in 10 quarters. The position peaked at $153K in Q2 2015. 265 funds tracked by Wall St. Rank hold EHC as of Q2 2016.

Thompson Davis & Co reported no remaining Encompass Health position as of Q2 2016 after selling out during the quarter.
Thompson Davis & Co sold 4,022 Encompass Health shares in Q2 2016, an estimated $120K.
Thompson Davis & Co first reported a position in Encompass Health in Q4 2013 and held it in 10 quarters.
Thompson Davis & Co's Encompass Health position peaked at $153K in Q2 2015.
265 funds tracked by Wall St. Rank held Encompass Health as of Q2 2016.

Based on Thompson Davis & Co's 13F filing for Q2 2016, filed 9 Aug 2016.